Role of TGFB Receptor Alterations in Pancreatic Cancer

TGFB 受体改变在胰腺癌中的作用

• 批准号: 6784589
• 负责人: James W. Freeman
• 金额: $ 27.45万
• 依托单位: UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
• 依托单位国家: 美国
• 财政年份: 1997
• 资助国家: 美国
• 起止时间: 1997-08-01 至 2007-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6784589
• 关键词: apoptosis; athymic mouse; biological signal transduction; gel mobility shift assay; gene induction /repression; growth factor receptors; guanine nucleotide binding protein; methylation; mutant; neoplasm /cancer genetics; neoplastic process; nucleic acid sequence; pancreas neoplasms; polymerase chain reaction; protein structure function; receptor expression; southern blotting; tissue /cell culture; transforming growth factors; tumor suppressor genes

DESCRIPTION (provided by applicant): We established that loss of expression of TbetaRII causes a lack of response to TGFbeta in a population of pancreatic ductal adenocarcinoma cells (PDAC) that otherwise has an intact SMAD pathway. The loss of TbetaRII expression was most often caused by transcriptional repression involving oncogenic ras signaling, methylation, and HDAC and not by a mutation of the RII gene. Interestingly, we found that loss of TGFbeta signaling contributed to the deregulation of IGF-1R expression found in PDAC. The biologic consequences of loss of TGFbeta responsiveness in PDAC include a relaxation of growth controls and an increase in resistance to apoptosis through modulation of bcl-family members. We propose to test the hypotheses that: (1) there is a convergence between oncogenic ras signaling and epigenetic mechanisms leading to a transcriptional repression of the T?RII gene. To address this hypothesis we will determine the mechanism(s) by which ras signaling, methylation and HDAC regulate TbetaRII expression and determine whether there is a molecular linkage among these processes. To accomplish this we propose to (a) elucidate the transcriptional components of the T?RII gene affected by ras signaling, methylation and HDAC and (b) determine whether there is a molecular linkage among ras, methylation and HDAC in causing transcriptional repression of the T?RII gene. (2) the loss of TGFbeta signaling favors growth factor independence and resistance to apoptosis, in part, by promoting deregulation of lGF-1R expression. To address this hypothesis we will determine the biologic consequence of TGFbeta-mediated suppression of IGF-1R signaling in PDAC. To accomplish this we propose to (a) determine whether loss of autocrine TGFbeta signaling represents a common mechanism for deregulation of IGF-1R expression in PDAC, (b) determine whether TGFbeta signaling regulates IGF-IR expression through c-Myc and (c) determine the biologic significance of the interaction of IGF-IR and TGFbeta pathways in cell cycle regulation and tumorigenicity. Developing strategies to overcome transcriptional repression of TbetaRII may provide a new approach for therapy and for increasing sensitivity of PDAC to chemotherapy or radiation.

描述（由申请人提供）：我们确定TbetaRII表达的缺失导致胰腺导管腺癌细胞（PDAC）群体对TGF β缺乏应答，否则该细胞群体具有完整的SMAD途径。TbetaRII表达的缺失最常由涉及致癌ras信号传导、甲基化和HDAC的转录抑制引起，而不是由RII基因突变引起。有趣的是，我们发现TGF β信号的丢失导致了PDAC中IGF-1 R表达的失调。PDAC中TGF β反应性丧失的生物学后果包括生长控制的放松和通过调节bcl家族成员而增加对凋亡的抗性。我们建议测试的假设，即：（1）有一个致癌ras信号和表观遗传机制之间的收敛，导致T？RII基因。为了解决这一假设，我们将确定ras信号传导、甲基化和HDAC调节TbetaRII表达的机制，并确定这些过程之间是否存在分子联系。为了实现这一点，我们建议（a）阐明T？（B）RII基因受ras信号、甲基化和HDAC的影响;（3）RII基因受ras信号、甲基化和HDAC的影响; RII基因。(2)TGF β信号传导的丧失部分地通过促进IGF-1 R表达的失调而有利于生长因子独立性和对凋亡的抗性。为了解决这一假设，我们将确定TGF β介导的IGF-1 R信号转导抑制PDAC的生物学后果。为了实现这一点，我们建议（a）确定自分泌TGF β信号的丧失是否代表PDAC中IGF-1 R表达失调的常见机制，（B）确定TGF β信号是否通过c-Myc调节IGF-IR表达，以及（c）确定IGF-IR和TGF β途径在细胞周期调节和致瘤性中相互作用的生物学意义。开发克服TbetaRII转录抑制的策略可能为治疗和增加PDAC对化疗或放疗的敏感性提供新的方法。